Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miyuki Azuma

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Clinical Oral Investigations|January 26, 2019
Deep sequencing reveals specific bacterial signatures in the subgingival microbiota of healthy subjectsEri Ikeda, Takahiko Shiba, Yuichi Ikeda, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 13, 2004
Accessory cell function of airway epithelial cellsErwin Oei, Thomas Kalb, Prarthana Beuria, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cellsVrajesh V Parekh, Saif Lalani, Sungjune Kim, et al.
The Journal of Investigative Dermatology|April 13, 2019
Silencing of PD-L2/B7-DC by Topical Application of Small Interfering RNA Inhibits Elicitation of Contact HypersensitivityEmi Furusawa, Tatsukuni Ohno, Shigenori Nagai, et al.
Journal of Oral Biosciences|February 19, 2026
Impaired PD-1 expression in tumor-infiltrating senescent CD8<sup>+</sup> T cells is reversed by PD-L1 blockade in a murine squamous cell carcinoma modelYi Lu, Yuya Su, Yuto Nagatomo, et al.
Biochemical and Biophysical Research Communications|August 19, 2019
Endogenous IL-33 exerts CD8<sup>+</sup> T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma modelYulong Xia, Tatsukuni Ohno, Naoto Nishii, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitisBing Zhu, Indira Guleria, Arezou Khosroshahi, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|October 25, 2017
Correlation of Circulating CD64<sup>+</sup>/CD163<sup>+</sup> Monocyte Ratio and stroma/peri-tumoral CD163<sup>+</sup> Monocyte Density with Human Papillomavirus Infected Cervical Lesion SeverityPiyawut Swangphon, Chamsai Pientong, Nuchsupha Sunthamala, et al.
Frontiers in Psychology|June 5, 2023
Cooperation and competition between the default mode network and frontal parietal network in the elderlyHideya Koshino, Mariko Osaka, Tetsuya Shimokawa, et al.
Transplantation|January 16, 2004
Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigenOsamu Aramaki, Nozomu Shirasugi, Tadatoshi Takayama, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Clinical Oral Investigations|January 26, 2019
Deep sequencing reveals specific bacterial signatures in the subgingival microbiota of healthy subjectsEri Ikeda, Takahiko Shiba, Yuichi Ikeda, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 13, 2004
Accessory cell function of airway epithelial cellsErwin Oei, Thomas Kalb, Prarthana Beuria, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cellsVrajesh V Parekh, Saif Lalani, Sungjune Kim, et al.
The Journal of Investigative Dermatology|April 13, 2019
Silencing of PD-L2/B7-DC by Topical Application of Small Interfering RNA Inhibits Elicitation of Contact HypersensitivityEmi Furusawa, Tatsukuni Ohno, Shigenori Nagai, et al.
Journal of Oral Biosciences|February 19, 2026
Impaired PD-1 expression in tumor-infiltrating senescent CD8<sup>+</sup> T cells is reversed by PD-L1 blockade in a murine squamous cell carcinoma modelYi Lu, Yuya Su, Yuto Nagatomo, et al.
Biochemical and Biophysical Research Communications|August 19, 2019
Endogenous IL-33 exerts CD8<sup>+</sup> T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma modelYulong Xia, Tatsukuni Ohno, Naoto Nishii, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitisBing Zhu, Indira Guleria, Arezou Khosroshahi, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|October 25, 2017
Correlation of Circulating CD64<sup>+</sup>/CD163<sup>+</sup> Monocyte Ratio and stroma/peri-tumoral CD163<sup>+</sup> Monocyte Density with Human Papillomavirus Infected Cervical Lesion SeverityPiyawut Swangphon, Chamsai Pientong, Nuchsupha Sunthamala, et al.
Frontiers in Psychology|June 5, 2023
Cooperation and competition between the default mode network and frontal parietal network in the elderlyHideya Koshino, Mariko Osaka, Tetsuya Shimokawa, et al.
Transplantation|January 16, 2004
Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigenOsamu Aramaki, Nozomu Shirasugi, Tadatoshi Takayama, et al.
Pageof 16